Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
Autor principal: | Hyde, S |
---|---|
Formato: | Conference item |
Publicado em: |
2013
|
Registos relacionados
-
Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
Por: Veselu, D-F, et al.
Publicado em: (2024) -
A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
Por: Alton, EWFW, et al.
Publicado em: (2016) -
Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
Por: Davies, L, et al.
Publicado em: (2014) -
A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis
Por: Alton, E, et al.
Publicado em: (2015) -
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
Por: McLachlan, G, et al.
Publicado em: (2011)